Bio Protocol Price

Bio Protocol (BIO) is a cryptocurrency launched in 2025. It operates as a curation and liquidity layer for Decentralized Science (DeSci), directly connecting patient, researcher, and investor communities with tokenized biotechnology assets.

The protocol targets the structural inefficiency of early-stage biomedical funding—a domain where traditional venture capital routinely bypasses high-risk longevity science and rare disease research. Communities use the platform to collectively fund and govern tokenized biotech intellectual property, transforming passive capital allocators into active stakeholders in drug development pipelines. This model compresses the decades-long translational gap between lab discovery and clinical trial.

Bio Protocol operates on the Ethereum network. Token contracts exist natively on Solana, BNB Chain, and Base, embedding the asset into multiple high-liquidity environments simultaneously. Such multi-chain architecture helps circumvent isolated liquidity silos that often fragment niche scientific tokens.

The token adheres to the ERC-20 standard on Ethereum, with bridged representations on the other integrated networks. All contract addresses are publicly verifiable through Etherscan, Solscan, and BscScan. This cross-chain deployment avoids relying on any single chain’s security model while maintaining full auditability for community oversight.

The project’s origins trace to Molecule, a tokenization framework for early-stage biomedicine, and VitaDAO, the world’s largest decentralized longevity research collective. The core contributors launched BIO in January 2025 as a dedicated financial layer to scale those precursor experiments into a full economic flywheel for onchain scientific commercialization.

The protocol’s long-term purpose is to unbundle institution-dominated biomedical funding and reassemble it as a globally accessible, community-owned public good. Rather than relying on patent-heavy pharma incumbents, BIO seeks to turn intellectual property into liquid, composable digital assets that patient communities and researchers govern directly.

Token holders use BIO to stake into curation pools that signal which sub-communities or specific IP tokens deserve funding priority. The token also acts as a membership instrument, granting admission to specialized DeSci DAOs, and as a settlement asset for liquidity provision across tokenized biotech portfolios. These mechanical functions calibrate participant incentives without centralized intermediaries.

Researchers and patient advocacy groups acquire BIO to launch new biotech-focused DAOs and propose funding rounds. Liquidity providers deposit BIO into automated market making pools tied to tokenized IP, capturing trading fees and protocol emissions. Holding the asset gives exposure to a diversified basket of early-stage biomedical projects without requiring direct company stock.

Bio Protocol has a maximum supply of 3,320,000,000 tokens. Currently, 1,769,745,956.34 are in circulation. With a market capitalization of $53,963,851, Bio Protocol ranks #455 among all cryptocurrencies.